Single Administration of Tripeptide α-MSH(11-13) Attenuates Brain Damage by Reduced Inflammation and Apoptosis after Experimental Traumatic Brain Injury in Mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Schaible, Eva Verena ^a   Steinsträßer, Arne ^a   Jahn Eimermacher, Antje ^b   Luh, Clara ^a   Sebastiani, Anne ^a   Kornes, Frida ^a   Pieter, Dana ^a   Schäfer, Michael K ^a   Engelhard, Kristin ^a   Thal, Serge C ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA MELANOCYTE STIMULATING HORMONE[11-13]; BIOLOGICAL MARKER; CASPASE 3; INTERLEUKIN 1BETA; IONIZED CALCIUM BINDING ADAPTOR MOLECULE 1; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 4 RECEPTOR; NEURON SPECIFIC NUCLEAR PROTEIN; NEUROPROTECTIVE AGENT; PROOPIOMELANOCORTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENCEPHALITIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IL 1BETA GENE; MALE; MARKER GENE; MC1R GENE; MC4R GENE; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROOPIOMELANOCORTIN GENE; PROTEIN EXPRESSION; SINGLE DRUG DOSE; TNF ALPHA GENE; TRAUMATIC BRAIN INJURY;

MUS;

EID: 84881087148     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071056     Document Type: Article

References (66)

1. Manna SK, Sarkar A, Sreenivasan Y, (2006) Alpha-melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. European journal of immunology 36: 754-769.
2. Getting SJ, (2002) Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy. Trends in pharmacological sciences 23: 447-449.
3. Huang QH, Hruby VJ, Tatro JB, (1998) Systemic alpha-MSH suppresses LPS fever via central melanocortin receptors independently of its suppression of corticosterone and IL-6 release. The American journal of physiology 275: R524-530.
4. Taylor AW, Streilein JW, Cousins SW, (1992) Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Current eye research 11: 1199-1206.
5. Taylor AW, Streilein JW, Cousins SW, (1994) Alpha-melanocyte-stimulating hormone suppresses antigen-stimulated T cell production of gamma-interferon. Neuroimmunomodulation 1: 188-194.
6. Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, et al. (1997) alpha-MSH modulates local and circulating tumor necrosis factor-alpha in experimental brain inflammation. The Journal of neuroscience: the official journal of the Society for Neuroscience 17: 2181-2186.
7. Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, et al. (1996) Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. Journal of immunology 156: 2517-2521.
8. Hruby VJ, Wilkes BC, Hadley ME, Al-Obeidi F, Sawyer TK, et al. (1987) alpha-Melanotropin: the minimal active sequence in the frog skin bioassay. Journal of medicinal chemistry 30: 2126-2130.
9. Delgado R, Carlin A, Airaghi L, Demitri MT, Meda L, et al. (1998) Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. Journal of leukocyte biology 63: 740-745.
10. Getting SJ, Schioth HB, Perretti M, (2003) Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. The Journal of pharmacology and experimental therapeutics 306: 631-637.
11. Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S, et al. (2004) alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. The Journal of investigative dermatology 122: 1010-1019.
12. Land SC, (2012) Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. Int J Physiol Pathophysiol Pharmacol 4: 59-73.
13. Mountjoy KG, (2010) Distribution and function of melanocortin receptors within the brain. Advances in experimental medicine and biology 681: 29-48.
14. Spaccapelo L, Bitto A, Galantucci M, Ottani A, Irrera N, et al. (2011) Melanocortin MC receptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia. European journal of pharmacology 670: 479-486.
15. Thal SC, Wyschkon S, Pieter D, Engelhard K, Werner C, (2008) Selection of endogenous control genes for normalization of gene expression analysis after experimental brain trauma in mice. J Neurotrauma 25: 785-794.
16. Thal SC, Heinemann M, Luh C, Pieter D, Werner C, et al. (2011) Pioglitazone reduces secondary brain damage after experimental brain trauma by PPAR-gamma-independent mechanisms. Journal of neurotrauma 28: 983-993.
17. Tsenter J, Beni-Adani L, Assaf Y, Alexandrovich AG, Trembovler V, et al. (2008) Dynamic changes in the recovery after traumatic brain injury in mice: effect of injury severity on T2-weighted MRI abnormalities, and motor and cognitive functions. J Neurotrauma 25: 324-333.
18. Luh C, Kuhlmann CR, Ackermann B, Timaru-Kast R, Luhmann HJ, et al. (2010) Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury. Journal of neurochemistry 112: 1015-1025.
19. Davis EJ, Foster TD, Thomas WE, (1994) Cellular forms and functions of brain microglia. Brain Res Bull 34: 73-78.
20. Tatro JB, (1996) Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation 3: 259-284.
21. Catania A, Lonati C, Sordi A, Carlin A, Leonardi P, et al. (2010) The melanocortin system in control of inflammation. TheScientificWorldJournal 10: 1840-1853.
22. Charnley M, Moir AJ, Douglas CW, Haycock JW, (2008) Anti-microbial action of melanocortin peptides and identification of a novel X-Pro-D/L-Val sequence in Gram-positive and Gram-negative bacteria. Peptides 29: 1004-1009.
23. Nahon JL (2006) The melanocortins and melanin-concentrating hormone in the central regulation of feeding behavior and energy homeostasis. Comptes rendus biologies 329: 623-638; discussion 653-625.
24. Zierath D, Tanzi P, Cain K, Shibata D, Becker K, (2011) Plasma alpha-melanocyte stimulating hormone predicts outcome in ischemic stroke. Stroke; a journal of cerebral circulation 42: 3415-3420.
25. Savos AV, Gee JM, Zierath D, Becker KJ, (2011) alpha-MSH: a potential neuroprotective and immunomodulatory agent for the treatment of stroke. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 31: 606-613.
26. Todd SR, Kao LS, Catania A, Mercer DW, Adams SD, et al. (2009) Alpha-melanocyte stimulating hormone in critically injured trauma patients. The Journal of trauma 66: 465-469.
27. Magnoni S, Stocchetti N, Colombo G, Carlin A, Colombo A, et al. (2003) Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. Journal of neurotrauma 20: 251-260.
28. Cone RD, (2005) Anatomy and regulation of the central melanocortin system. Nature neuroscience 8: 571-578.
29. Xia Y, Wikberg JE, Chhajlani V, (1995) Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 6: 2193-2196.
30. Wong KY, Rajora N, Boccoli G, Catania A, Lipton JM, (1997) A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation 4: 37-41.
31. de Angelis E, Sahm UG, Ahmed AR, Olivier GW, Notarianni LJ, et al. (1995) Identification of a melanocortin receptor expressed by murine brain microvascular endothelial cells in culture. Microvascular research 50: 25-34.
32. Dessinioti C, Antoniou C, Katsambas A, Stratigos AJ, (2011) Melanocortin 1 receptor variants: functional role and pigmentary associations. Photochemistry and photobiology 87: 978-987.
33. Caruso C, Durand D, Schioth HB, Rey R, Seilicovich A, et al. (2007) Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 148: 4918-4926.
34. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, et al. (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. The Journal of biological chemistry 268: 15174-15179.
35. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD, (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Molecular endocrinology 8: 1298-1308.
36. Kishi T, Aschkenasi CJ, Lee CE, Mountjoy KG, Saper CB, et al. (2003) Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat. The Journal of comparative neurology 457: 213-235.
37. Caruso C, Mohn C, Karara AL, Rettori V, Watanobe H, et al. (2004) Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 79: 278-286.
38. Bitto A, Polito F, Irrera N, Calo M, Spaccapelo L, et al. (2012) Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury*. Critical care medicine 40: 945-951.
39. Catania A, Gatti S, Colombo G, Lipton JM, (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacological reviews 56: 1-29.
40. Chen G, Frokiaer J, Pedersen M, Nielsen S, Si Z, et al. (2008) Reduction of ischemic stroke in rat brain by alpha melanocyte stimulating hormone. Neuropeptides 42: 331-338.
41. Forslin Aronsson S, Spulber S, Popescu LM, Winblad B, Post C, et al. (2006) alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides 40: 65-75.
42. van de Meent H, Hamers FP, Lankhorst AJ, Joosten EA, Gispen WH (1997) Beneficial effects of the melanocortin alpha-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery 40: 122-130; discussion 130-121.
43. Wilson JF, Harry FM, (1980) Release, distribution and half-life of alpha-melanotrophin in the rat. The Journal of endocrinology 86: 61-67.
44. Springer JE, (2002) Apoptotic cell death following traumatic injury to the central nervous system. Journal of biochemistry and molecular biology 35: 94-105.
45. Stoica BA, Faden AI, (2010) Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics 7: 3-12.
46. Chai B, Li JY, Zhang W, Newman E, Ammori J, et al. (2006) Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase. Peptides 27: 2846-2857.
47. Giuliani D, Mioni C, Altavilla D, Leone S, Bazzani C, et al. (2006) Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 147: 1126-1135.
48. Giuliani D, Zaffe D, Ottani A, Spaccapelo L, Galantucci M, et al. (2011) Treatment of cerebral ischemia with melanocortins acting at MC(4) receptors induces marked neurogenesis and long-lasting functional recovery. Acta neuropathologica 122: 443-453.
49. Maas AI, Stocchetti N, Bullock R, (2008) Moderate and severe traumatic brain injury in adults. Lancet neurology 7: 728-741.
50. Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK, (2001) The duality of the inflammatory response to traumatic brain injury. Molecular neurobiology 24: 169-181.
51. Clark RS, Schiding JK, Kaczorowski SL, Marion DW, Kochanek PM, (1994) Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. Journal of neurotrauma 11: 499-506.
52. Wada K, Chatzipanteli K, Kraydieh S, Busto R, Dietrich WD, (1998) Inducible nitric oxide synthase expression after traumatic brain injury and neuroprotection with aminoguanidine treatment in rats. Neurosurgery 43: 1427-1436.
53. Cernak I, (2006) Recent advances in neuroprotection for treating traumatic brain injury. Expert opinion on investigational drugs 15: 1371-1381.
54. Timaru-Kast R, Wyschkon S, Luh C, Schaible EV, Lehmann F, et al. (2012) Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma*. Critical care medicine 40: 935-944.
55. Haddad JJ, Lauterbach R, Saade NE, Safieh-Garabedian B, Land SC, (2001) Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: evidence for involvement of an interleukin-1beta193-195 receptor antagonism in the alveolar epithelium. The Biochemical journal 355: 29-38.
56. Ichiyama T, Sakai T, Catania A, Barsh GS, Furukawa S, et al. (1999) Systemically administered alpha-melanocyte-stimulating peptides inhibit NF-kappaB activation in experimental brain inflammation. Brain research 836: 31-37.
57. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, et al. (2008) PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 134: 166-178.
58. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nature neuroscience 8: 752-758.
59. Rupalla K, Allegrini PR, Sauer D, Wiessner C, (1998) Time course of microglia activation and apoptosis in various brain regions after permanent focal cerebral ischemia in mice. Acta neuropathologica 96: 172-178.
60. Csuka E, Hans VH, Ammann E, Trentz O, Kossmann T, et al. (2000) Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport 11: 2587-2590.
61. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, et al. (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Annals of neurology 70: 374-383.
62. Faden AI, (2011) Microglial activation and traumatic brain injury. Annals of neurology 70: 345-346.
63. Loane DJ, Byrnes KR, (2010) Role of microglia in neurotrauma. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics 7: 366-377.
64. Chen S, Pickard JD, Harris NG, (2003) Time course of cellular pathology after controlled cortical impact injury. Experimental neurology 182: 87-102.
65. Zhang Z, Artelt M, Burnet M, Trautmann K, Schluesener HJ, (2006) Early infiltration of CD8+ macrophages/microglia to lesions of rat traumatic brain injury. Neuroscience 141: 637-644.
66. Loane DJ, Faden AI, (2010) Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends in pharmacological sciences 31: 596-604.